CCES To Acquire New York-Based Healthcare Claims Processing Company.

Business Editors & Health/Technology Writers

HOUSTON--(BUSINESS WIRE)--April 17, 2002

Crescent Communications Inc. (OTCBB:CCES) announced it has signed a non-binding Letter of Intent to acquire privately held MB Associates Inc., a Fishkill, N.Y.-based healthcare claims processing company (www.medi-bill.com) for $1 million in stock. In addition, a principal of MB Associates will purchase $500,000 in new common stock from CCES at its current market price. For the year ended Dec. 31, 2001, MB Associates Inc. generated a small profit on revenues of approximately $1.7 million processing approximately $25 million in healthcare claims. The agreement is subject to signing of a Definitive Agreement which includes standard due diligence, representations, warranties, covenants, indemnifications and conditions customary for transactions of this type and is expected to close by May 31, 2002.

"Crescent jumpstarts its Healthcare Claims Processing division by acquiring MB Associates," stated Manfred Sternberg, CEO. "MB Associates is a proven fee-based medical claims processing company delivering vital financial services to its base of physician clients. Crescent, through its HIPAA compliant hi-speed secure Internet connectivity pipeline will now be able to provide the 'Last Mile' directly to the physician's office through our strategy of wiring the professional buildings and offices that physicians occupy. With the pending eMedical Records Online purchase and now MB Associates, we have an excellent conduit to provide online claims processing and other medical and financial services for the healthcare industry. We only have to feed the pipeline with additional claims processing and other revenue-producing opportunities to generate a substantial increase in revenues."

"We are truly looking forward to this relationship," said Sid Dinerstein, principal of MB Associates Inc. "Medi-Bill should enhance the Crescent vision to become the leader in the healthcare market by delivering add value applications and services."

About Crescent Communications Inc.

Crescent Communications (OTCBB:CCES), headquartered in Houston, is a healthcare technology holding company, focusing on providing industry-specific solutions for the federally mandated Health Insurance Portability and Accountability Act ("HIPAA") legislation. This legislation requires the health care industry to process all health care information, including billing, through a secure data interchange as mandated by the Secretary of Health and Human Services, as of October 2003. Crescent's business strategy is divided into three key areas: HIPAA Solutions (an integrated service solution division); Electronic Data Interchange (a verification organization); and Secure Medical Networks ("SMN") (a broadband digital connectivity for medical office buildings). All three divisions work seamlessly together to provide a "total solution" for the entire health care industry. Crescent's recently formed Health Care Division will integrate "front-end" point of service transactions with "back-end" administrative processes. Integrated solutions will be available through Electronic Data Interchange (EDI); Electronic Data Interchange (EDI) includes real-time electronic eligibility, physician practice management with electronic transactions, claims status and history, and provider identification.

About MB Associates Inc.

MB Associates is an innovative medical billing organization whose Advance Funding program is revolutionizing the medical billing industry. MB's staff is trained in all areas of medical billing, including coding and follow-up. MB's current client list contains physicians in a wide variety of medical specialties. MB Associates' Advance Funding Program pays physicians or other health care practitioners on their assigned primary claims within 72 hours. This program is one of the most effective ways to accelerate a medical practice's cash flow.

This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.